DNA损伤应答靶向抑制剂对卵巢癌细胞的化疗增敏作用
Employing DNA Damage Response Inhibitors to Enhance Chemosensitivity of Ovarian Carcinoma Cells
-
摘要: 目的 观察DNA损伤应答抑制剂及其联合常规化疗药物(顺铂等)在卵巢癌耐药细胞株OVCAR-8中的作用,研究其化疗致敏效应。方法 利用针对DNA损伤应答关键信号蛋白质的抑制剂,与顺铂等连用处理卵巢癌细胞,分析这些药物处理方式对卵巢癌细胞的杀伤能力。MTT法检测不同药物作用后OVCAR-8的增殖抑制情况;免疫荧光法检测OVCAR-8中磷酸化组蛋白2A变体(γH2AX)和p53结合蛋白1(53BP1)的表达,观察二者在DNA损伤位点的募集和形成灶点的能力。结果 毛细血管扩张共济失调突变蛋白(ATM)/ATM和Rad 3相关蛋白(ATR)抑制剂与顺铂联用能抑制损伤修复机制的活化,明显减弱OVCAR-8细胞的增殖活力(P<0.01),促进其凋亡;在羟基脲和Wortmannin联合处理时,OVCAR-8细胞的ATR转导信号(如γH2AX)减弱,细胞生存率明显降低(P<0.05);多聚ADP-核糖聚合酶(PARP)抑制剂与顺铂联合处理OVCAR-8细胞未发现明显的增敏作用(P>0.05)。结论 适当的DNA损伤应答抑制剂有潜力提高常规化疗药物的抗肿瘤效果,以达到快速清除肿瘤细胞和防止产生耐药性的效果。Abstract: Objective To assess the sensitisation effects of DDR inhibitors combined with conventional chemotherapeutics agents (cisplatin et al) in a drug-resistant ovarian cancer cell line(OVCAR-8). Methods Inhibitors of DDR regulators with cisplatin were applied to challenge OVCAR-8, and evaluated the DNA damage response (DDR) and cytotoxic effects of different combination of chemicals. Inhibition of proliferation to OVCAR-8 of different drugs was evaluated by MTT assay. The activation of phosphorylation of histone family 2A variant(γH2AX) and p53 binding protein 1 (53BP1) in OVCAR-8 were evaluated by immunofluorescence to observe their ability of recruitment and forming foci at DNA damage site. Results We observed that combined treatment of ataxia-telangiectasia mutated(ATM)/ATM and Rad 3-related(ATR) inhibitor and cisplatin can suppress the activation of damage repair mechanisms and weakened the proliferative activity of OVCAR-8 cells (P<0.01); ATR pathway was suppressed and the signal of γH2AX weakened and cell survival rate significantly reduced when combination therapy of HU and Wortmannin (P<0.05); poly ADP-ribose polymerase (PARP) inhibitor could not enhance chemosensitivity in OVCAR-8 cells when combined with cisplatin (P>0.05). Conclusion We substantiated that appropriate inhibitors of DNA damage response may have a potential to improve the anti-tumor effect of conventional chemotherapy drugs and prevent drug resistances.
© 2016 《koko体育app
学报(医学版)》编辑部 版权所有
开放获取💛 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问